Greenwich LifeSciences Inc (GLSI) ニュース

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 

STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe 

STAFFORD, Texas, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

STAFFORD, Texas, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 

STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Greenwich LifeSciences Provides Update on Commercial Manufacturing

STAFFORD, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

STAFFORD, Texas, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France 

STAFFORD, Texas, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities